Amgen Inc - Ebit

Amgen Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Ebit" stands at 11.11 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 12/31/2023.

Amgen Inc's third quarter result of 4.61 Billion USD for the item "Ebit" represents an increase of 102.37 percent compared to it's second quarter result.

Also, Amgen Inc's third quarter result of 4.61 Billion USD for the item "Ebit" represents an increase of 18.80 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Amgen Inc's third quarter result of 11.11 Billion USD for the item "Ebit" represents an increase of 7.02 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 40.45 percent compared to the value the year prior.
The 1 year change in percent is 40.45.
The 3 year change in percent is 22.66.
The 5 year change in percent is 17.11.
The 10 year change in percent is 31.87.

The Serie's long term average value is 8.74 Billion United States Dollars. It's latest available value, on 09/30/2025, is 27.03 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2011, to it's latest available value, on 09/30/2025, is +133.34%.
The Serie's change in percent from it's maximum value, on 06/30/2023, to it's latest available value, on 09/30/2025, is -1.48%.